Clinical Trial

Evaluation of Indian Gooseberry/ Amla in the Management of Chronic Periodontitis

Completed
View on ClinicalTrials.gov →
Summary
This study aimed to evaluate the influence of amla (Emblica officinalis) on patients with chronic generalized periodontitis, using a single-blind, randomized controlled study design. 1. At baseline, all participants fulfilling the I/E criteria would be randomized into Arm I or II. 2. All participants in Arm I and II would undergo scaling and root planing (SRP). 3. After 1 month, Arm I participants would receive adjunct amla for 2 weeks, and Arm II participants would receive no treatment. 4. Both arms would be followed until the end of 6 months and evaluated for clinical and biochemical parameters.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-13.
Trial Details
NCT Number NCT07531823
Lead Sponsor Mahatma Gandhi Postgraduate Institute of Dental Sciences
Conditions Chronic Periodontitis
Enrollment 30 participants
Start Date 2020-03-20
Primary Completion 2022-03-15 (estimated)
Study Completion 2022-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-21